Pancreatic Cancer Research

ResearcherUniversity of AntwerpNo recent work listed

Jinthe Van Loenhout

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8576-5640; OpenAlex author ID A5066563229. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment. Co-author DOI 10.1002/cti2.1165↗
  2. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers11101597↗
  3. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells. Co-author DOI 10.18632/oncotarget.18185↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Evelien Smits · 3 shared papers, 2017–2020 · strength 0.23
  2. Jonas R.M. Van Audenaerde · 3 shared papers, 2017–2020 · strength 0.23
  3. Marc Peeters · 3 shared papers, 2017–2020 · strength 0.23
  4. Geert Roeyen · 2 shared papers, 2017–2020 · strength 0.15
  5. Delphine Quatannens · 1 shared paper, 2020 · strength 0.09
  6. Clare Y. Slaney · 1 shared paper, 2020 · strength 0.09
  7. Christophe Deben · 1 shared paper, 2019 · strength 0.08
  8. Annemie Bogaerts · 1 shared paper, 2019 · strength 0.08
  9. Atsushi Masamune · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.